Risk factors for chronic rejection in pediatric renal allograft recipients

被引:21
作者
Guyot, C
Nguyen, JM
Cochat, P
Foulard, M
Bouissou, F
VanDammeLombaerts, R
Loirat, C
Janssen, F
Bensman, A
Nivet, H
Fischbach, M
Guignard, JP
Andre, JL
机构
[1] Néphrologie Pediat., Centre Hospitalier Régional, Nantes
[2] Unité de Statistiques, Ctr. Hosp. Régional, Nantes
[3] U. de Nephrologie Pediat., Hôpital Harriot, Lyon
[4] U. de Nephrologie Pediat., Hôpital Calmette, Lille
[5] Médecine Infantile C, Hôpital Purpan, Toulouse
[6] Pediatric Nephrology, Kinderziekenhuis, Leuven
[7] Serv. de Néphrologie Pediat., Hôpital Robert Debré, Paris
[8] Néphrologie Pediat., Hôpital d'Enfants, Brussels
[9] Serv. de Néphrologie Pediat., Hôpital Trousseau, Paris
[10] Néphrologie Pediat., Ctr. Hosp. Régional, Tours
[11] Pédiatrie 3, Hôpital de Hautepierre, Strasbourg
[12] Pédiatrie Néphrologie, Ctr. Hosp. Régional Vaudois, Lausanne
[13] Néphrologie Pediat., Hôpital d'Enfants, Nancy
[14] Néphrologie Pediat., Ctr. Hosp. Reg. Universitaire
关键词
renal transplantation; acute rejection; chronic rejection; cyclosporine;
D O I
10.1007/s004670050199
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To determine the risk factors predictive of graft loss from chronic rejection in pediatric renal allograft recipients, we reviewed the collaborative study database of the Societe de Nephrologie Pediatrique which registered 314 grafts from January 1987 to December 1991. Of the 289 grafts analyzed, 71 failed during follow-up, chronic rejection being the most common cause of graft loss (35%). The clinical features of the chronic rejection group (n = 25) were compared with those of the group without failure (n = 218). The variables tested by monovariate analysis were cyclosporine dose at 1 year, donor type, donor and recipient age, and acute rejection episodes. The incidence of graft loss due to chronic rejection was 4% (4/109) in patients who had no acute rejection and 16% (21/134) in those with at least one acute rejection episode (P = 0.002). Donor age (less than or equal to 5 years) was a risk factor for chronic rejection (P = 0.024). Recipient age and donor type were not significantly different between the chronic rejection group and the control group. Using time-dependent covariates, the risk factors were an acute rejection episode (P = 0.003) and low cyclosporine doses at 1 year (P = 0.02). We conclude that acute rejection and low cyclosporine doses in these pediatric patients were risk factors for graft loss due to chronic rejection.
引用
收藏
页码:723 / 727
页数:5
相关论文
共 23 条
[1]   RISK-FACTORS FOR CHRONIC REJECTION IN RENAL-ALLOGRAFT RECIPIENTS [J].
ALMOND, PS ;
MATAS, A ;
GILLINGHAM, K ;
DUNN, DL ;
PAYNE, WD ;
GORES, P ;
GRUESSNER, R ;
NAJARIAN, JS ;
FERGUSON ;
PAUL ;
SCHAFFER .
TRANSPLANTATION, 1993, 55 (04) :752-757
[2]   EARLY VERSUS LATE ACUTE RENAL-ALLOGRAFT REJECTION - IMPACT ON CHRONIC REJECTION [J].
BASADONNA, GP ;
MATAS, AJ ;
GILLINGHAM, KJ ;
PAYNE, WD ;
DUNN, DL ;
SUTHERLAND, DER ;
GORES, PF ;
GRUESSNER, RWG ;
NAJARIAN, JS .
TRANSPLANTATION, 1993, 55 (05) :993-995
[3]   WEIGHT-INDEPENDENT DOSING OF CYCLOSPORINE - AN ALTERNATIVE TO THE MG/KG DOCTRINE [J].
BOCK, HA ;
KAMBER, V ;
BRUNNER, FP ;
THIEL, G .
TRANSPLANTATION, 1994, 57 (10) :1484-1489
[4]  
Broyer M, 1987, Adv Nephrol Necker Hosp, V16, P307
[5]   LONG-TERM EFFICACY AND SAFETY OF CYCLOSPORINE IN RENAL-TRANSPLANT RECIPIENTS [J].
BURKE, JF ;
PIRSCH, JD ;
RAMOS, EL ;
SALOMON, DR ;
STABLEIN, DM ;
VANBUREN, DH ;
WEST, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (06) :358-363
[6]   CAUSES OF KIDNEY ALLOGRAFT LOSS IN A LARGE PEDIATRIC POPULATION AT A SINGLE-CENTER [J].
CHAVERS, BM ;
KIM, EM ;
MATAS, AJ ;
GILLINGHAM, KJ ;
NAJARIAN, JS ;
MAUER, SM .
PEDIATRIC NEPHROLOGY, 1994, 8 (01) :57-61
[7]   CAUSES OF GRAFT LOSS BEYOND 2 YEARS IN THE CYCLOSPORINE ERA [J].
DUNN, J ;
GOLDEN, D ;
VANBUREN, CT ;
LEWIS, RM ;
LAWEN, J ;
KAHAN, BD .
TRANSPLANTATION, 1990, 49 (02) :349-353
[8]   EVIDENCE THAT ZERO ANTIGEN-MATCHED CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS HAVE GRAFT-SURVIVAL EQUAL TO THAT OF MATCHED RECIPIENTS - REEVALUATION OF POINTS [J].
GREENSTEIN, SM ;
SCHECHNER, RS ;
LOUIS, P ;
SENITZER, D ;
MATAS, A ;
VEITH, FJ ;
TELLIS, VA .
TRANSPLANTATION, 1990, 49 (02) :332-336
[9]  
GUYOT C, 1994, TRANSPLANT P, V26, P22
[10]  
HRICIK DE, 1993, P AM SOC TRANSPL PHY, P58